Hiroshi Nakatani

Keio University, Edo, Tōkyō, Japan

Are you Hiroshi Nakatani?

Claim your profile

Publications (1)0.9 Total impact

  • Source
    Yoshinaga Kawano · Junichiro Irie · Hiroshi Nakatani · Satoru Yamada
    [Show abstract] [Hide abstract]
    ABSTRACT: Although recent studies recommended that insulin should be administered to patients with slowly progressive type 1 diabetes, even those with non-insulin dependent status, patients prefer oral hypoglycemic agents to insulin injections. We report a slowly progressive type 1 diabetic patient whose insulin production was preserved for 4 years (SigmaC-peptide from 29.48 ng/mL to 24.58 ng/mL) using pioglitazone despite a high titer of anti-GAD antibody (GADA; 120.7 U/mL). This case suggests that pioglitazone might prevent or delay the loss of insulin secretion and insulin dependency in slowly progressive type 1 diabetic patients.
    Internal Medicine 02/2009; 48(12):1037-9. DOI:10.2169/internalmedicine.48.1990 · 0.90 Impact Factor